Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.

Saved in:
Bibliographic Details
Title: Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
Authors: Le Joncour V; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Guichet PO; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Dembélé KP; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Mutel A; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Campisi D; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Perzo N; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Desrues L; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Modzelewski R; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France., Couraud PO; Université de Paris, Institut Cochin, Inserm U1016, CNRS UMR 8104, Paris, France., Honnorat J; Neuro-Oncology Department, Hospices Civils de Lyon, Hôpital Neurologique, Bron, France.; Institute NeuroMyoGéne, INSERM U1217/CNRS UMR 5310, Lyon, France.; University Claude Bernard Lyon 1, Université de Lyon, Lyon, France., Ferracci FX; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.; Neurosurgery Service, Rouen CHU Hospital, Rouen, France., Marguet F; Anathomocytopathology Service, Rouen CHU Hospital, Rouen, France., Laquerrière A; Anathomocytopathology Service, Rouen CHU Hospital, Rouen, France., Vera P; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France., Bohn P; EA 4108, Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes (LITIS), University of Rouen, Mont-Saint-Aignan, France., Langlois O; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.; Neurosurgery Service, Rouen CHU Hospital, Rouen, France., Morin F; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Gandolfo P; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France., Castel H; UNIROUEN, INSERM U1239, DC2N, Institute for Research and Innovation in Biomedicine (IRIB), Normandie Rouen Université, Rouen, France.
Source: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Apr 14; Vol. 9, pp. 652544. Date of Electronic Publication: 2021 Apr 14 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2296-634X
DOI:10.3389/fcell.2021.652544